KA
Abouir, Kenza
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID-19 Patients : A Physiologically Based Pharmacokinetic Modeling Study | Clinical pharmacology and therapeutics |  | 2025 | 71 | 376 | ||
| Assessing the intrinsic and extrinsic factors of pharmacokinetic variability for precision medicine: A focus on CYP2C19 and the influence of genetic polymorphisms on drug interactions |  | 2024 | 343 | 14 | |||
| Stereoselective separation of omeprazole and 5-hydroxy-omeprazole using dried plasma spots and a heart-cutting 2D-LC approach for accurate CYP2C19 phenotyping | Journal of chromatography. B | | 2024 | 110 | 123 | ||
| Dexamethasone and Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia | JAMA | | 2022 | 172 | 0 | ||
| Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trial | Clinical and translational science | | 2022 | 158 | 154 | ||
| Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging Trends | Frontiers in pharmacology | | 2021 | 186 | 338 |
